Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the surgical outcomes and the quality of life (QOL) in patients undergoing hepatic artery infusion pump placement for colorectal liver metastases (CRLM).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Quality of Life | Self-reported quality of life and recovery from surgery using a questionnaire to investigate changes over time. | Baseline prior to surgery. |
| Quality of Life | Self-reported quality of life and recovery from surgery using a questionnaire to investigate changes over time. | Postoperative day 2. |
| Quality of Life | Self-reported quality of life and recovery from surgery using a questionnaire to investigate changes over time. | Postoperative day 7. |
| Quality of Life | Self-reported quality of life and recovery from surgery using a questionnaire to investigate changes over time. | Postoperative day 14. |
| Quality of Life | Self-reported quality of life and recovery from surgery using a questionnaire to investigate changes over time. | Postoperative day 30. |
| Quality of Life | Self-reported quality of life and recovery from surgery using a questionnaire to investigate changes over time. | Postoperative day 60. |
| Quality of Life | Self-reported quality of life and recovery from surgery using a questionnaire to investigate changes over time. | Postoperative day 90. |
| Measure | Description | Time Frame |
|---|---|---|
| Time to start chemotherapy | Number of days following hepatic artery infusion pump placement until chemotherapy is started | 1 month postoperatively |
| Surgical outcomes | Complications with hepatic artery infusion pump placement |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patients with colorectal liver metastases (CRLM) being offered Hepatic Artery Infusion Pump placement and subsequent Hepatic Artery Infusion Chemotherapy at Mayo Clinic Rochester will be evaluated to participate in this study.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Cornelius Thiels, DO, MBA | Mayo Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mayo Clinic Rochester | Rochester | Minnesota | 55905 | United States |
Not provided
| Label | URL |
|---|---|
| Mayo Clinic Clinical Trials | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D015179 | Colorectal Neoplasms |
| ID | Term |
|---|---|
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
Not provided
Not provided
Not provided
Not provided
Not provided
| Quality of Life |
Self-reported quality of life and recovery from surgery using a questionnaire to investigate changes over time. |
| Postoperative day 120. |
| Quality of Life | Self-reported quality of life and recovery from surgery using a questionnaire to investigate changes over time. | Postoperative day 150. |
| Quality of Life | Self-reported quality of life and recovery from surgery using a questionnaire to investigate changes over time. | Postoperative day 180. |
| 1 month postoperatively |
| Surgical outcomes | Complications with hepatic artery infusion chemotherapy | 6 month postoperatively |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D012002 | Rectal Diseases |